S
S. Andrew Peng
Researcher at Durham University
Publications - 20
Citations - 660
S. Andrew Peng is an academic researcher from Durham University. The author has contributed to research in topics: Myocardial infarction & Percutaneous coronary intervention. The author has an hindex of 12, co-authored 19 publications receiving 566 citations. Previous affiliations of S. Andrew Peng include University of Texas MD Anderson Cancer Center & Duke University.
Papers
More filters
Journal ArticleDOI
Use and Outcomes of Triple Therapy Among Older Patients With Acute Myocardial Infarction and Atrial Fibrillation.
Connie N. Hess,Eric D. Peterson,S. Andrew Peng,James A. de Lemos,Emil L. Fosbøl,Laine Thomas,Deepak L. Bhatt,Jorge F. Saucedo,Tracy Y. Wang +8 more
TL;DR: Nearly 1 in 4 older AF patients undergoing PCI for MI were discharged on triple therapy, and those receiving triple therapy versus DAPT had higher rates of major bleeding without a measurable difference in composite MI, death, or stroke.
Journal ArticleDOI
Differences in the profile, treatment, and prognosis of patients with cardiogenic shock by myocardial infarction classification: A report from NCDR
Monique L Anderson,Eric D. Peterson,S. Andrew Peng,Tracy Y. Wang,E. Magnus Ohman,Deepak L. Bhatt,Jorge F. Saucedo,Matthew T. Roe +7 more
TL;DR: In this paper, the authors characterize differences in patient features, treatments, and outcomes of cardiogenic shock by MI classification: ST-segment-elevation MI (STEMI) versus non-st-segments elevation MI (NSTEMI).
Journal ArticleDOI
Emergency department bypass for ST-Segment-elevation myocardial infarction patients identified with a prehospital electrocardiogram: a report from the American Heart Association Mission: Lifeline program.
Akshay Bagai,James G. Jollis,Harold L. Dauerman,S. Andrew Peng,Ivan C. Rokos,Eric R. Bates,William J. French,Christopher B. Granger,Matthew T. Roe +8 more
TL;DR: Because ED bypass was associated with shorter reperfusion times and numerically lower mortality rates, further exploration of and advocacy for the implementation of this process appear warranted.
Journal ArticleDOI
Early clopidogrel versus prasugrel use among contemporary STEMI and NSTEMI patients in the US: insights from the National Cardiovascular Data Registry.
Matthew W. Sherwood,Stephen D. Wiviott,S. Andrew Peng,Matthew T. Roe,James deLemos,Eric D. Peterson,Tracy Y. Wang +6 more
TL;DR: With prasugrel as an antiplatelet treatment option, contemporary practice shows low uptake of pr asugrel and delays in P2Y12 antagonist initiation among NSTEMI patients.
Journal ArticleDOI
Improving Care of STEMI in the United States 2008 to 2012
Christopher B. Granger,Eric R. Bates,James G. Jollis,Elliott M. Antman,Graham Nichol,Robert E. O'Connor,Tammy Gregory,Mayme L. Roettig,S. Andrew Peng,Gray Ellrodt,Timothy D. Henry,William J. French,Alice K. Jacobs +12 more
TL;DR: In this paper, the change in treatment strategies and times to treatment over the first 5 years of the Mission: Lifeline program was assessed and the results showed that the change was relatively mild.